Erythromycin derivatives
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 30, 2004
Grant Date -
Apr 8, 2004
app pub date -
Apr 8, 2003
filing date -
Jan 2, 1998
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The invention relates to novel erythromycin derivatives, particularly ones with novel C-13 R.sup.13 substitutents, and to pharmaceutically acceptable salts thereof. The compounds of this invention are useful as antibacterial agents and antiprotozoa agents and for other applications (e.g., anticancer, atherosclerosis, gastric motility reduction, etc.) in mammals, including man, as well as in fish and. The invention also relates to pharmaceutical compositions containing such compounds and to methods of treating bacterial protozoa infections by administering such compounds. The invention also relates to methods of preparing such compounds and to intermediates useful in such preparation.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully